Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2013 1
2014 1
2015 1
2016 1
2017 4
2018 1
2020 2
2021 3
2022 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Behandlung refraktärer Anti-NXP2- und Anti-TIF1γ-Dermatomyositis mit Tofacitinib.
Navarro-Navarro I, Jiménez-Gallo D, Rodríguez-Mateos ME, Rodríguez-Hernández C, Linares-Barrios M. Navarro-Navarro I, et al. Among authors: rodriguez mateos me. J Dtsch Dermatol Ges. 2021 Mar;19(3):443-447. doi: 10.1111/ddg.14276_g. J Dtsch Dermatol Ges. 2021. PMID: 33709603 German. No abstract available.
Treatment of prurigo nodularis with lenalidomide.
Ossorio-García L, Jiménez-Gallo D, Rodríguez-Mateos ME, Arjona-Aguilera C, Linares-Barrios M. Ossorio-García L, et al. Among authors: rodriguez mateos me. Dermatol Ther. 2017 Mar;30(2). doi: 10.1111/dth.12451. Epub 2016 Nov 28. Dermatol Ther. 2017. PMID: 27891738
Effectiveness of ustekinumab for moderate-to-severe hidradenitis suppurativa: a case series.
Valenzuela-Ubiña S, Jiménez-Gallo D, Villegas-Romero I, Rodríguez-Mateos ME, Linares-Barrios M. Valenzuela-Ubiña S, et al. Among authors: rodriguez mateos me. J Dermatolog Treat. 2022 Mar;33(2):1159-1162. doi: 10.1080/09546634.2020.1776208. Epub 2020 Jun 11. J Dermatolog Treat. 2022. PMID: 32502365 Free article. No abstract available.
Treatment of refractory anti-NXP2 and anti-TIF1γ dermatomyositis with tofacitinib.
Navarro-Navarro I, Jiménez-Gallo D, Rodríguez-Mateos ME, Rodríguez-Hernández C, Linares-Barrios M. Navarro-Navarro I, et al. Among authors: rodriguez mateos me. J Dtsch Dermatol Ges. 2021 Mar;19(3):443-447. doi: 10.1111/ddg.14276. Epub 2020 Sep 10. J Dtsch Dermatol Ges. 2021. PMID: 32909360 No abstract available.
Off-label antineoplastic drugs. An effectiveness and safety study.
Arroyo Álvarez C, Rodríguez Pérez L, Rodríguez Mateos ME, Martínez Bautista MJ, Benítez Rodríguez E, Baena-Cañada JM. Arroyo Álvarez C, et al. Among authors: rodriguez mateos me. Farm Hosp. 2017 May 1;41(3):382-390. doi: 10.7399/fh.2017.41.3.10745. Farm Hosp. 2017. PMID: 28478752 English.
Implementation of safeguards to improve patient safety in chemotherapy.
Huertas-Fernández MJ, Martínez-Bautista MJ, Rodríguez-Mateos ME, Zarzuela-Ramírez M, Muñoz-Lucero T, Baena-Cañada JM. Huertas-Fernández MJ, et al. Among authors: rodriguez mateos me. Clin Transl Oncol. 2017 Sep;19(9):1099-1106. doi: 10.1007/s12094-017-1645-y. Epub 2017 Mar 30. Clin Transl Oncol. 2017. PMID: 28361329
13 results